Guiyang Xintian Pharmaceutical Co.,Ltd. (002873.SZ)
CNY 9.83
(0.1%)
CNY 9.83
(0.1%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 93.74 Million CNY | -23.27% |
| 2022 | 122.16 Million CNY | 4.32% |
| 2021 | 117.11 Million CNY | 35.62% |
| 2020 | 86.35 Million CNY | 3.5% |
| 2019 | 83.43 Million CNY | 11.86% |
| 2018 | 74.58 Million CNY | -0.17% |
| 2017 | 74.71 Million CNY | 21.25% |
| 2016 | 61.61 Million CNY | 43.02% |
| 2015 | 43.08 Million CNY | 25.2% |
| 2014 | 34.41 Million CNY | 154.03% |
| 2013 | 13.54 Million CNY | -46.9% |
| 2012 | 25.5 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 18.54 Million CNY | 280.68% |
| 2024 Q2 | 19.13 Million CNY | 3.15% |
| 2024 Q3 | 32.33 Million CNY | 69.04% |
| 2023 FY | 93.74 Million CNY | -23.27% |
| 2023 Q2 | 29.53 Million CNY | 14.04% |
| 2023 Q3 | 48.57 Million CNY | 64.49% |
| 2023 Q4 | -10.26 Million CNY | -121.13% |
| 2023 Q1 | 25.89 Million CNY | 380.79% |
| 2022 Q3 | 49.31 Million CNY | 50.21% |
| 2022 Q2 | 32.82 Million CNY | -5.23% |
| 2022 Q1 | 34.63 Million CNY | 121.35% |
| 2022 FY | 122.16 Million CNY | 4.32% |
| 2022 Q4 | 5.38 Million CNY | -89.08% |
| 2021 Q4 | 15.64 Million CNY | -65.39% |
| 2021 Q1 | 30.47 Million CNY | 92.9% |
| 2021 FY | 117.11 Million CNY | 35.62% |
| 2021 Q2 | 25.76 Million CNY | -15.43% |
| 2021 Q3 | 45.22 Million CNY | 75.49% |
| 2020 Q2 | 24.6 Million CNY | 247.52% |
| 2020 Q3 | 38.87 Million CNY | 58.02% |
| 2020 FY | 86.35 Million CNY | 3.5% |
| 2020 Q1 | 7.07 Million CNY | 266.26% |
| 2020 Q4 | 15.79 Million CNY | -59.37% |
| 2019 Q3 | 45.83 Million CNY | 117.93% |
| 2019 Q2 | 21.03 Million CNY | 0.99% |
| 2019 Q1 | 20.82 Million CNY | 1356.76% |
| 2019 FY | 83.43 Million CNY | 11.86% |
| 2019 Q4 | -4.25 Million CNY | -109.29% |
| 2018 Q4 | 1.42 Million CNY | -96.18% |
| 2018 Q1 | 19.92 Million CNY | 114.52% |
| 2018 FY | 74.58 Million CNY | -0.17% |
| 2018 Q2 | 15.76 Million CNY | -20.88% |
| 2018 Q3 | 37.46 Million CNY | 137.71% |
| 2017 Q1 | 16.03 Million CNY | 598.31% |
| 2017 FY | 74.71 Million CNY | 21.25% |
| 2017 Q4 | 9.28 Million CNY | -75.01% |
| 2017 Q3 | 37.16 Million CNY | 203.95% |
| 2017 Q2 | 12.22 Million CNY | -23.76% |
| 2016 FY | 61.61 Million CNY | 43.02% |
| 2016 Q2 | 15.16 Million CNY | 7.57% |
| 2016 Q3 | 30.05 Million CNY | 98.11% |
| 2016 Q1 | 14.1 Million CNY | 14.71% |
| 2016 Q4 | 2.29 Million CNY | -92.36% |
| 2015 Q4 | 12.29 Million CNY | 0.0% |
| 2015 Q2 | 16.87 Million CNY | 0.0% |
| 2015 Q1 | 16.87 Million CNY | 28.36% |
| 2015 FY | 43.08 Million CNY | 25.2% |
| 2015 Q3 | 12.29 Million CNY | -27.16% |
| 2014 Q1 | 9.85 Million CNY | 0.0% |
| 2014 Q2 | 9.85 Million CNY | -0.0% |
| 2014 FY | 34.41 Million CNY | 154.03% |
| 2014 Q3 | 13.14 Million CNY | 33.4% |
| 2014 Q4 | 13.14 Million CNY | 0.0% |
| 2013 FY | 13.54 Million CNY | -46.9% |
| 2012 FY | 25.5 Million CNY | 0.0% |